Cargando…

Blood and urinary metabolomic evidence validating traditional Chinese medicine diagnostic classification of major depressive disorder

BACKGROUND: Major depressive disorder (MDD) is a highly heterogeneous disease. Further classification may characterize its heterogeneity. The purpose of this study was to examine whether metabolomic variables could differentiate traditional Chinese medicine (TCM) diagnostic subtypes of MDD. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Lan-Ying, Zhang, Hong-Jian, Luo, Li-Yuan, Pu, Jin-Bao, Liang, Wei-Qing, Zhu, Chun-Qin, Li, Ya-Ping, Wang, Pei-Rong, Zhang, Yuan-Yuan, Yang, Chun-Yu, Zhang, Zhang-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203264/
https://www.ncbi.nlm.nih.gov/pubmed/30386416
http://dx.doi.org/10.1186/s13020-018-0211-z
_version_ 1783365848119902208
author Liu, Lan-Ying
Zhang, Hong-Jian
Luo, Li-Yuan
Pu, Jin-Bao
Liang, Wei-Qing
Zhu, Chun-Qin
Li, Ya-Ping
Wang, Pei-Rong
Zhang, Yuan-Yuan
Yang, Chun-Yu
Zhang, Zhang-Jin
author_facet Liu, Lan-Ying
Zhang, Hong-Jian
Luo, Li-Yuan
Pu, Jin-Bao
Liang, Wei-Qing
Zhu, Chun-Qin
Li, Ya-Ping
Wang, Pei-Rong
Zhang, Yuan-Yuan
Yang, Chun-Yu
Zhang, Zhang-Jin
author_sort Liu, Lan-Ying
collection PubMed
description BACKGROUND: Major depressive disorder (MDD) is a highly heterogeneous disease. Further classification may characterize its heterogeneity. The purpose of this study was to examine whether metabolomic variables could differentiate traditional Chinese medicine (TCM) diagnostic subtypes of MDD. METHODS: Fifty medication-free patients who were experiencing a recurrent depressive episode were classified into Liver Qi Stagnation (LQS, n = 30) and Heart and Spleen Deficiency (HSD, n = 20) subtypes according to TCM diagnosis. Healthy volunteers (n = 28) were included as controls. Gas chromatography-mass spectrometry (GC–MS) was used to examine serum and urinary metabolomic profiles. RESULTS: Twenty-eight metabolites were identified for good separations between TCM subtypes and healthy controls in serum samples. Both TCM subtypes had similar profiles in proteinogenic branched-chain amino acids (BCAAs) (valine, leucine, and isoleucine) and energy metabolism-related metabolites that were differentiated from healthy controls. The LQS subtype additionally differed from healthy controls in multiple amino acid metabolites that are involved in biosynthesis of monoamine and amino acid neurotransmitters, including phenylalanine, 3-hydroxybutric acid, o-tyrosine, glycine, l-tryptophan, and N-acetyl-l-aspartic acid. Threonic acid, methionine, stearic acid, and isobutyric acid are differentially associated with the two subtypes. CONCLUSIONS: While both TCM subtypes are associated with aberrant BCAA and energy metabolism, the LQS subtype may represent an MDD subpopulation characterized by abnormalities in the biosynthesis of monoamine and amino acid neurotransmitters and closer associations with stress-related pathophysiology. The metabolites differentially associated with the two subtypes are promising biomarkers for predicting TCM subtype-specific antidepressant response [registered at http://www.clinicaltrials.gov (NCT02346682) on January 27, 2015]. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13020-018-0211-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6203264
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62032642018-11-01 Blood and urinary metabolomic evidence validating traditional Chinese medicine diagnostic classification of major depressive disorder Liu, Lan-Ying Zhang, Hong-Jian Luo, Li-Yuan Pu, Jin-Bao Liang, Wei-Qing Zhu, Chun-Qin Li, Ya-Ping Wang, Pei-Rong Zhang, Yuan-Yuan Yang, Chun-Yu Zhang, Zhang-Jin Chin Med Research BACKGROUND: Major depressive disorder (MDD) is a highly heterogeneous disease. Further classification may characterize its heterogeneity. The purpose of this study was to examine whether metabolomic variables could differentiate traditional Chinese medicine (TCM) diagnostic subtypes of MDD. METHODS: Fifty medication-free patients who were experiencing a recurrent depressive episode were classified into Liver Qi Stagnation (LQS, n = 30) and Heart and Spleen Deficiency (HSD, n = 20) subtypes according to TCM diagnosis. Healthy volunteers (n = 28) were included as controls. Gas chromatography-mass spectrometry (GC–MS) was used to examine serum and urinary metabolomic profiles. RESULTS: Twenty-eight metabolites were identified for good separations between TCM subtypes and healthy controls in serum samples. Both TCM subtypes had similar profiles in proteinogenic branched-chain amino acids (BCAAs) (valine, leucine, and isoleucine) and energy metabolism-related metabolites that were differentiated from healthy controls. The LQS subtype additionally differed from healthy controls in multiple amino acid metabolites that are involved in biosynthesis of monoamine and amino acid neurotransmitters, including phenylalanine, 3-hydroxybutric acid, o-tyrosine, glycine, l-tryptophan, and N-acetyl-l-aspartic acid. Threonic acid, methionine, stearic acid, and isobutyric acid are differentially associated with the two subtypes. CONCLUSIONS: While both TCM subtypes are associated with aberrant BCAA and energy metabolism, the LQS subtype may represent an MDD subpopulation characterized by abnormalities in the biosynthesis of monoamine and amino acid neurotransmitters and closer associations with stress-related pathophysiology. The metabolites differentially associated with the two subtypes are promising biomarkers for predicting TCM subtype-specific antidepressant response [registered at http://www.clinicaltrials.gov (NCT02346682) on January 27, 2015]. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13020-018-0211-z) contains supplementary material, which is available to authorized users. BioMed Central 2018-10-25 /pmc/articles/PMC6203264/ /pubmed/30386416 http://dx.doi.org/10.1186/s13020-018-0211-z Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Liu, Lan-Ying
Zhang, Hong-Jian
Luo, Li-Yuan
Pu, Jin-Bao
Liang, Wei-Qing
Zhu, Chun-Qin
Li, Ya-Ping
Wang, Pei-Rong
Zhang, Yuan-Yuan
Yang, Chun-Yu
Zhang, Zhang-Jin
Blood and urinary metabolomic evidence validating traditional Chinese medicine diagnostic classification of major depressive disorder
title Blood and urinary metabolomic evidence validating traditional Chinese medicine diagnostic classification of major depressive disorder
title_full Blood and urinary metabolomic evidence validating traditional Chinese medicine diagnostic classification of major depressive disorder
title_fullStr Blood and urinary metabolomic evidence validating traditional Chinese medicine diagnostic classification of major depressive disorder
title_full_unstemmed Blood and urinary metabolomic evidence validating traditional Chinese medicine diagnostic classification of major depressive disorder
title_short Blood and urinary metabolomic evidence validating traditional Chinese medicine diagnostic classification of major depressive disorder
title_sort blood and urinary metabolomic evidence validating traditional chinese medicine diagnostic classification of major depressive disorder
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203264/
https://www.ncbi.nlm.nih.gov/pubmed/30386416
http://dx.doi.org/10.1186/s13020-018-0211-z
work_keys_str_mv AT liulanying bloodandurinarymetabolomicevidencevalidatingtraditionalchinesemedicinediagnosticclassificationofmajordepressivedisorder
AT zhanghongjian bloodandurinarymetabolomicevidencevalidatingtraditionalchinesemedicinediagnosticclassificationofmajordepressivedisorder
AT luoliyuan bloodandurinarymetabolomicevidencevalidatingtraditionalchinesemedicinediagnosticclassificationofmajordepressivedisorder
AT pujinbao bloodandurinarymetabolomicevidencevalidatingtraditionalchinesemedicinediagnosticclassificationofmajordepressivedisorder
AT liangweiqing bloodandurinarymetabolomicevidencevalidatingtraditionalchinesemedicinediagnosticclassificationofmajordepressivedisorder
AT zhuchunqin bloodandurinarymetabolomicevidencevalidatingtraditionalchinesemedicinediagnosticclassificationofmajordepressivedisorder
AT liyaping bloodandurinarymetabolomicevidencevalidatingtraditionalchinesemedicinediagnosticclassificationofmajordepressivedisorder
AT wangpeirong bloodandurinarymetabolomicevidencevalidatingtraditionalchinesemedicinediagnosticclassificationofmajordepressivedisorder
AT zhangyuanyuan bloodandurinarymetabolomicevidencevalidatingtraditionalchinesemedicinediagnosticclassificationofmajordepressivedisorder
AT yangchunyu bloodandurinarymetabolomicevidencevalidatingtraditionalchinesemedicinediagnosticclassificationofmajordepressivedisorder
AT zhangzhangjin bloodandurinarymetabolomicevidencevalidatingtraditionalchinesemedicinediagnosticclassificationofmajordepressivedisorder